Article

Features of treatment and rehabilitation of COVID-19 patients with ischemic stroke

G. RakhimbayevaTashkent Medical AcademyS GazievaTashkent Medical AcademyMakhsudjan AtaniyazovTashkent Medical AcademyFakhmitdin MuratovTashkent Medical AcademyD S TolipovTashkent Medical AcademyU D ShodievTashkent Medical Academy

S S Korsakov Journal of Neurology and Psychiatryjournal2023en

ABI

Abstract

The development of COVID-19 is associated with damage to various organs and organ systems, including the development of acute ischemic stroke (AI). The article examines modern ideas about the pathogenesis of AI in COVID-19. The data on the choice of optimal therapy for patients with acute AI and COVID-19, as well as on the possibility of improving the effectiveness of rehabilitation measures, are analyzed. Information is provided on the efficacy of the drug Mexidol in patients with AI and COVID-19.

Topics

Long-Term Effects of COVID-19 Neurological Disorders and Treatments COVID-19 Clinical Research Studies

Identifiers

DOI: 10.17116/jnevro202312303276

Citations and references

Cited by 053 references

Metrics — AkademScholar · Coming soon